Cargando…

Serum survivin predicts responses to treatment in active rheumatoid arthritis: a post hoc analysis from the SWEFOT trial

BACKGROUND: The identification of biomarkers that predict optimal and individual choices of treatment for patients with rheumatoid arthritis gains increasing attention. The purpose of this study was to investigate if the proto-oncogene survivin might aid in treatment decisions in early rheumatoid ar...

Descripción completa

Detalles Bibliográficos
Autores principales:	Levitsky, Adrian, Erlandsson, Malin C., van Vollenhoven, Ronald F., Bokarewa, Maria I.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4589197/ https://www.ncbi.nlm.nih.gov/pubmed/26420684 http://dx.doi.org/10.1186/s12916-015-0485-2

Ejemplares similares

Obesity is a strong predictor of worse clinical outcomes and treatment responses in early rheumatoid arthritis: results from the SWEFOT trial
por: Levitsky, Adrian, et al.
Publicado: (2017)

Suppressed diversity of survivin splicing in active rheumatoid arthritis
por: Turkkila, Minna, et al.
Publicado: (2015)

Current smoking status is a strong predictor of radiographic progression in early rheumatoid arthritis: results from the SWEFOT trial
por: Saevarsdottir, Saedis, et al.
Publicado: (2015)

Changes in the anticitrullinated peptide antibody response in relation to therapeutic outcome in early rheumatoid arthritis: results from the SWEFOT trial
por: Kastbom, Alf, et al.
Publicado: (2016)

Survivin but not Fms-like tyrosine kinase 3 ligand is up-regulated before the onset of rheumatoid arthritis: a pilot study
por: Bokarewa, Maria, et al.
Publicado: (2014)

Association of a multibiomarker disease activity score at multiple time-points with radiographic progression in rheumatoid arthritis: results from the SWEFOT trial
por: Hambardzumyan, Karen, et al.
Publicado: (2016)

Evaluation of hand bone loss by digital X-ray radiogrammetry as a complement to clinical and radiographic assessment in early rheumatoid arthritis: results from the SWEFOT trial
por: Rezaei, Hamed, et al.
Publicado: (2013)

Smoking in combination with antibodies to cyclic citrullinated peptides is associated with persistently high levels of survivin in early rheumatoid arthritis: a prospective cohort study
por: Svensson, Björn, et al.
Publicado: (2014)

Recognizing Rheumatoid Arthritis: Oncoprotein Survivin Opens New Possibilities: A Population-based Case–Control Study
por: Chun-Lai, Too, et al.
Publicado: (2015)

Cost-effectiveness of infliximab versus conventional combination treatment in methotrexate-refractory early rheumatoid arthritis: 2-year results of the register-enriched randomised controlled SWEFOT trial
por: Eriksson, Jonas K, et al.
Publicado: (2015)

Activation of Fms-Like Tyrosine Kinase 3 Signaling Enhances Survivin Expression in a Mouse Model of Rheumatoid Arthritis
por: Andersson, Sofia E. M., et al.
Publicado: (2012)

Survivin promotes a glycolytic switch in CD4(+) T cells by suppressing the transcription of PFKFB3 in rheumatoid arthritis
por: Erlandsson, Malin C., et al.
Publicado: (2022)

Survivin Measurement improves Clinical Prediction of Transition From Arthralgia to RA—Biomarkers to Improve Clinical Sensitivity of Transition From Arthralgia to RA
por: Erlandsson, Malin C., et al.
Publicado: (2018)

Pretreatment multi-biomarker disease activity score and radiographic progression in early RA: results from the SWEFOT trial
por: Hambardzumyan, Karen, et al.
Publicado: (2015)

Clinical Significance of Diabetes-Mellitus-Associated Antibodies in Rheumatoid Arthritis
por: Erlandsson, Malin C., et al.
Publicado: (2022)

Smoking Functions as a Negative Regulator of IGF1 and Impairs Adipokine Network in Patients with Rheumatoid Arthritis
por: Erlandsson, Malin C., et al.
Publicado: (2016)

Low serum IGF1 is associated with hypertension and predicts early cardiovascular events in women with rheumatoid arthritis
por: Erlandsson, Malin C., et al.
Publicado: (2019)

Low Soluble Receptor for Advanced Glycation End Products Precedes and Predicts Cardiometabolic Events in Women With Rheumatoid Arthritis
por: Nadali, Mitra, et al.
Publicado: (2021)

Balance between survivin, a key member of the apoptosis inhibitor family, and its specific antibodies determines erosivity in rheumatoid arthritis
por: Bokarewa, Maria, et al.
Publicado: (2005)

The impact of tofacitinib on fatigue, sleep, and health-related quality of life in patients with rheumatoid arthritis: a post hoc analysis of data from Phase 3 trials
por: Bartlett, Susan J., et al.
Publicado: (2022)

Prognostic Significance of BIRC5/Survivin in Breast Cancer: Results from Three Independent Cohorts
por: Oparina, Nina, et al.
Publicado: (2021)

High Expression of STAT3 in Subcutaneous Adipose Tissue Associates with Cardiovascular Risk in Women with Rheumatoid Arthritis
por: Nadali, Mitra, et al.
Publicado: (2017)

Smoking Is Associated With Low Levels of Soluble PD-L1 in Rheumatoid Arthritis
por: Wasén, Caroline, et al.
Publicado: (2018)

Metabolic signature and proteasome activity controls synovial migration of CDC42(hi) CD14(+) cells in rheumatoid arthritis
por: Malmhäll-Bah, Eric, et al.
Publicado: (2023)

Survivin is an essential mediator of arthritis interacting with urokinase signalling
por: Baran, Marcin, et al.
Publicado: (2009)

Impact of the Uncoupling Protein 1 on Cardiovascular Risk in Patients with Rheumatoid Arthritis
por: Lyngfelt, Lovisa I., et al.
Publicado: (2021)

Survivin co-ordinates formation of follicular T-cells acting in synergy with Bcl-6
por: Andersson, Karin M.E., et al.
Publicado: (2015)

Advances in the treatment of rheumatoid arthritis
por: Vivar, Nancy, et al.
Publicado: (2014)

Nicotine Changes the microRNA Profile to Regulate the FOXO Memory Program of CD8(+) T Cells in Rheumatoid Arthritis
por: Wasén, Caroline, et al.
Publicado: (2020)

Serum calprotectin levels do not predict subsequent relapse in rheumatoid arthritis in remission: a post-hoc analysis of STRASS study
por: Romand, Xavier, et al.
Publicado: (2023)

Low Serum IGF-1 in Boys with Recent Onset of Juvenile Idiopathic Arthritis
por: Lundell, Anna-Carin, et al.
Publicado: (2018)

Sex differences in rheumatoid arthritis: more than meets the eye...
por: van Vollenhoven, Ronald F
Publicado: (2009)

Prediction of flare following remission and treatment withdrawal in early rheumatoid arthritis: post hoc analysis of a phase IIIb trial with abatacept
por: Ahmad, Harris A., et al.
Publicado: (2022)

Inflammation in the hippocampus affects IGF1 receptor signaling and contributes to neurological sequelae in rheumatoid arthritis
por: Andersson, Karin M. E., et al.
Publicado: (2018)

Survivin prevents the polycomb repressor complex 2 from methylating histone 3 lysine 27
por: Jensen, Maja, et al.
Publicado: (2023)

Evaluating the efficacy of upadacitinib in patients with moderate rheumatoid arthritis: a post-hoc analysis of the SELECT phase 3 trials
por: Conaghan, Philip G, et al.
Publicado: (2023)

Efficacy and safety of tofacitinib in patients with rheumatoid arthritis by previous treatment: post hoc analysis of phase II/III trials
por: Tesser, John, et al.
Publicado: (2023)

Concomitant Use of Statins in Tocilizumab-Treated Patients with Rheumatoid Arthritis: A Post Hoc Analysis
por: Soubrier, Martin, et al.
Publicado: (2016)

A somatization comorbidity phenotype impacts response to therapy in rheumatoid arthritis: post-hoc results from the certolizumab pegol phase 4 PREDICT trial
por: Curtis, Jeffrey R., et al.
Publicado: (2017)

Sustained biologic-free and drug-free remission in rheumatoid arthritis, where are we now?
por: Nagy, György, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_6o60mp3u8kpn6r4roseh3b4u44